Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iressa and Casodex in Locally Advanced Prostate Cancer
NCT00319787Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in prostate cancer (PCa), sponsored by AstraZeneca. Started Dec 2003; status: completed.
02
Drugs
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00319787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319787.